VIM and colorectal carcinoma: Thus, by using the methyl BEAMing method, Li et al. demonstrated that plasma methylated Vimentin could be detected in the about 40–60% of curable CRC at stage I to III, and that the sensitivity of detection was higher than that of the serum value of CEA [21].